Skip to main content
Želite da licitirate na javnim nabavkama? Pogledajte našu uslugu pripreme tendera TaaS
Tenderi

NHS brendirani lekovi Tranche A - NOFE i Midlands & East i Natalizumab za London & SOFE - 1. septembar 2026.

Otvoreno
Rok
ostalo 13 dana
April 17, 2026
Detalji ugovora
Kategorija
Open Procedure
Referenca
023990-2026
Vrednost
£1,053,204,684
Lokacija
North East England, Ujedinjeno Kraljevstvo
Objavljeno
Mart 28, 2026
Organizacija
CPV šifra
Vremenski okvir projekta

Objavljen tender

Mart 17, 2026

Rok za pitanja

April 10, 2026

Rok za podnošenje ponuda

April 17, 2026

Datum početka ugovora

Avgust 31, 2026

Informacije o naručiocuPRO
🔒
Otključajte informacije o naručiocu
Pogledajte obrasce potrošnje, preferirane procedure i još mnogo toga.
Nadogradite na Profesionalni paket →
Budžet
£1,053,204,684
Trajanje
24 meseci
Lokacija
North East England
Tip
Open Procedure
75
Rezultat kvaliteta/100
Dobro

Originalni opis tendera

NHS Okvirni sporazum za brendirane lekove – Lot 1 – Tranche A za Severnu Englesku i Midlands & East. Period važenja Okvirnog sporazuma: od 1. septembra 2026. do 31. avgusta 2028. uz mogućnost ili mogućnosti produženja (po diskreciji ovlašćenog organa na dodatnih 24 meseca. Lot 2 – Natalizumab za London i Južnu Englesku. Period važenja Okvirnog sporazuma: od 1. septembra 2026. do 31. avgusta 2027. uz mogućnost ili mogućnosti produženja na dodatnih 12 meseci.

Analiza rizika

Analiza rizika još uvek nije dostupna za tendere u ovoj zemlji. Trenutno podržano: Estonija, Poljska, Litvanija i Letonija.

Strategija za pobedu

Dobijte AI strategiju za pobedu prilagođenu ovom tenderu. Uključuje ocenu verovatnoće pobede, ključne prilike i izazove, preporučene oblasti fokusa za ponudu, uvide u konkurentsko pozicioniranje i konkretne preporuke za maksimiziranje vaših šansi.

Prijavite se

Konkurenti

Nadogradite da biste videli koje kompanije će se verovatno nadmetati na ovom tenderu, na osnovu istorijskih podataka o javnim nabavkama.

Prijavite se

Zahtevi i kvalifikacije

7 zahteva u 5 kategorija

Predaja (2)
Obavezno (1)
Usklađenost (2)
Tehnički (1)
Finansijski (1)
SUBMISSION REQUIREMENTS2
--Bids must be submitted by the deadline: 2026-04-17T13:00:00+01:00.
--Requirements are to be provided in English, Estonian, Latvian, Polish, and Lithuanian.
MANDATORY EXCLUSION GROUNDS1
--No specific mandatory exclusion grounds are detailed in the provided text.
ELIGIBILITY REQUIREMENTS2
--Bidders must be capable of supplying pharmaceutical products (CPV: 33600000).
--Bidders must be able to meet the requirements for Lot 1 (North of England and Midlands & East) or Lot 2 (London and South of England) or both.
TECHNICAL CAPABILITY REQUIREMENTS1
--No specific technical capability requirements are detailed in the provided text.
FINANCIAL REQUIREMENTS1
--No specific financial requirements are detailed in the provided text.

Pregled zahteva

Registrujte se da biste videli potpune zahteve i analizu

Dokumenti

Dobijte AI-generisane sažetke svih tenderskih dokumenata. Brzo razumejte šta svaki dokument sadrži bez čitanja stotina stranica — uključujući obim, uslove, kriterijume evaluacije i ključne obaveze.

Prijavite se
75
Dobro

Rezultat kvaliteta tendera

This tender is generally well-structured with a clear title, reference, and estimated value. However, it lacks specific details on evaluation criteria and technical/financial requirements, and the submission deadline may be tight.

Pregled rezultata

Zakonska usklađenost75/100

The tender adheres to standard open procedure and provides a CPV code. Deadlines are present, though the submission deadline could be considered short. No disputes are indicated. Regulatory compliance is assumed based on the provided information.

Jasnoća80/100

The description of the framework agreement and its lots is clear. Eligibility requirements are stated. However, the absence of specific technical and financial requirements, as well as evaluation criteria, reduces overall clarity.

Missing evaluation criteria specified
Potpunost70/100

Basic information such as title, reference, organization, value, and deadlines are present. The duration of the framework agreement is specified. However, crucial details regarding technical capabilities, financial standing, and evaluation criteria are missing, impacting completeness.

No specific technical capability requirements detailed
No specific financial requirements detailed
Pravičnost85/100

The tender is an open procedure, allowing broad access. The estimated value is disclosed. The division into lots promotes competition. No specific company tailoring is evident. The primary concern is the lack of detailed criteria, which could lead to subjective evaluation if not addressed.

Praktičnost65/100

The contract start date is specified. Financing information is not detailed. The tender mentions requirements in multiple languages, which is a positive aspect for broader participation. However, the lack of explicit e-submission details and the absence of document content in the provided text hinder practicality.

No e-submission specified
No document content available
Konzistentnost podataka90/100

Key fields like title, reference, organization, value, and deadlines are populated. Dates are logical and do not indicate suspension or disputes. The CPV code and NUTS code are provided.

Održivost50/100

There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. The tender is not indicated as EU funded.

Not green procurement
No social criteria

Prednosti

Clear title and reference number
Estimated value disclosed
Open procedure for broad participation
Division into lots
Requirements in multiple languages

Nedostaci

Missing specific technical and financial requirements
No evaluation criteria specified
Submission deadline may be too short
No document content available

Preporuke

1. Provide detailed technical and financial capability requirements.
2. Clearly define evaluation criteria.
3. Ensure sufficient time for bid preparation and submission.

Pregled AI ocene

Registrujte se da biste videli potpune zahteve i analizu

Potpuna analiza ocene kvaliteta
Detaljan pregled pod-ocena
Uvidi u prednosti i zabrinutosti
Strateške preporuke

Nije potrebna kreditna kartica • Podešavanje za 2 minuta

Nova usluga

Želite da prepustite nama ovaj tender?

Naši stručnjaci za javne nabavke pripremaju sve. Dokazano efikasno — Vi pregledate, odobrite i predate.

~1hVaše vreme
80%+80%+
$0Unapred
Pogledajte punu uporednu analizu
Bez TaaS-aSa TaaS-om
40-80 sati
Vreme pripreme
~1 sat
Vaše vreme
15-25%
Prosečan procenat uspešnosti
80%+
Procenat uspešnosti
Rizik od grešaka
Ručna provera
Stručna kontrola kvaliteta
Provera usaglašenosti
Sve radite Vi
Kompletna obrada
Sve radimo mi
Kompletna usluga
Dobijmo ovaj tender
Platite samo kada pobedite · Preko 400 kompanija nam veruje
Ili uradite sami

Dodaj u plan